TP53 and type 2 diabetes mellitus: In our case–control study, we demonstrated for the first time an association between the haptoglobin phenotype and the concentration of specific markers (sCD163, IL-10, HMGB1 and p53) regulating inflammatory processes in the body in patients with type 2 diabetes.